XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.46

-3.2%

12:09 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16785)	4/12/2004 5:31:51 PM
From: Cacaito	Read Replies (2) of 17367

Lps will promote killing and inactivation of the leukocytes (mainly, the neutrophils), they could suffer like any other cells, especially inmature ones from newborns (lots of decrease or absent functions to begin with on newborns leukocytes, even more with the more premature ones). Once you blocked and inactivate lps, not only the killing function improved, but also the disposition via catabolism to an inert form (actually, to an "edible" nutritious form) happens, but the survival and recrutiment of neutrophils improved! We are talking bpi, it seems to be!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next